American Association for Cancer Research

Skip to Main Content

Table 3

GST M1, T1, and P1 polymorphisms and RCC risk

	Cases (%)	Controls (%)	OR^a	95% CI	OR^b	95% CI
GSTM1
Present	63 (50.0)	250 (49.5)	1.0		1.0
Null	63 (50.0)	255 (50.5)	1.0	0.7–1.4	1.0	0.6–1.6
GSTT1
Present	90 (71.4)	411 (81.6)	1.0		1.0
Null	36 (28.6)	93 (18.5)	1.8	1.1–2.8	1.9	1.1–3.4
GSTP1 ^c
AA	58 (44.6)	213 (43.4)	1.0		1.0
AG	56 (43.1)	216 (44.0)	1.0	0.6–1.4	1.0	0.6–1.7
GG	16 (12.3)	62 (12.6)	0.9	0.5–1.8	1.0	0.4–2.0

	Cases (%)	Controls (%)	OR^a	95% CI	OR^b	95% CI
GSTM1
Present	63 (50.0)	250 (49.5)	1.0		1.0
Null	63 (50.0)	255 (50.5)	1.0	0.7–1.4	1.0	0.6–1.6
GSTT1
Present	90 (71.4)	411 (81.6)	1.0		1.0
Null	36 (28.6)	93 (18.5)	1.8	1.1–2.8	1.9	1.1–3.4
GSTP1 ^c
AA	58 (44.6)	213 (43.4)	1.0		1.0
AG	56 (43.1)	216 (44.0)	1.0	0.6–1.4	1.0	0.6–1.7
GG	16 (12.3)	62 (12.6)	0.9	0.5–1.8	1.0	0.4–2.0

^a

Crude ORs.

^b

ORs adjusted for age, sex, race, county,pack-years of smoking, and BMI.

^c

For combined categories GSTP1 AG and GG versus AA (OR, 1.0; 95% CI, 0.6–1.6).